9IRP
Structure of ClpP from Staphylococcus aureus in complex with ZG297
9IRP の概要
| エントリーDOI | 10.2210/pdb9irp/pdb |
| 分子名称 | ATP-dependent Clp protease proteolytic subunit, (6S,9aS)-6-[(2S)-butan-2-yl]-4,7-bis(oxidanylidene)-8-(phenanthren-9-ylmethyl)-N-[4,4,4-tris(fluoranyl)butyl]-3,6,9,9a-tetrahydro-2H-pyrazino[1,2-a]pyrimidine-1-carboxamide, MAGNESIUM ION, ... (4 entities in total) |
| 機能のキーワード | clpp, staphylococcus aureus, activator, protease, hydrolase |
| 由来する生物種 | Staphylococcus aureus |
| タンパク質・核酸の鎖数 | 14 |
| 化学式量合計 | 321368.28 |
| 構造登録者 | |
| 主引用文献 | Zhang, T.,Wang, P.,Zhou, H.,Wei, B.,Zhao, Y.,Li, J.,Zhang, M.,Wu, W.,Lan, L.,Gan, J.,Yang, C.G. Structure-guided development of selective caseinolytic protease P agonists as antistaphylococcal agents. Cell Rep Med, 5:101837-101837, 2024 Cited by PubMed Abstract: Methicillin-resistant Staphylococcus aureus is a ubiquitous pathogen, posing a serious threat to human health worldwide. Thus, there is a high demand for antibiotics with distinct targets. Caseinolytic protease P (ClpP) is a promising target for combating staphylococcal infections; however, selectively activating S. aureus ClpP (SaClpP) rather than Homo sapiens ClpP (HsClpP) remains challenging. Herein, we rationally design and identify ZG297 by structure-based strategy. It binds and activates SaClpP instead of HsClpP. This is due to differentiated ligand binding attributed to crossed "tyrosine/histidine" amino acid pairs. ZG297 substantially inhibits the growth of a broad panel of S. aureus strains in vitro, outperforming the selective (R)-ZG197 agonist. ZG297 also functions as a potent antibiotic against multidrug-resistant S. aureus infections in Galleria mellonella larvae, zebrafish, murine skin, and thigh infection models. Collectively, we demonstrate that ZG297 is a safer and more potent antistaphylococcal agent than acyldepsipeptide 4 and (R)-ZG197. PubMed: 39615486DOI: 10.1016/j.xcrm.2024.101837 主引用文献が同じPDBエントリー |
| 実験手法 | X-RAY DIFFRACTION (1.901 Å) |
構造検証レポート
検証レポート(詳細版)
をダウンロード






